Disc Medicine Inc (IRON) receives a Buy rating from Stifel

Daniel Torres

Disc Medicine Inc’s filing revealed that its Chief Legal Officer Khara Rahul unloaded Company’s shares for reported $0.51 million on Jan 02 ’26. In the deal valued at $78.69 per share,6,500 shares were sold. As a result of this transaction, Khara Rahul now holds 37,793 shares worth roughly $2.92 million.

Then, RAHUL KHARA bought 7,500 shares, generating $595,575 in total proceeds.

Before that, Bitterman Kevin sold 754 shares. Disc Medicine Inc shares valued at $68,968 were divested by the Director at a price of $91.47 per share. As a result of the transaction, Bitterman Kevin now holds 14,013 shares, worth roughly $1.08 million.

A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating.

Price Performance Review of IRON

On Tuesday, Disc Medicine Inc [NASDAQ:IRON] saw its stock fall -1.62% to $77.36. Over the last five days, the stock has lost -1.19%. Disc Medicine Inc shares have risen nearly 23.88% since the year began. Nevertheless, the stocks have fallen -2.58% over the past one year. While a 52-week high of $99.50 was reached on 01/02/26, a 52-week low of $30.82 was recorded on 01/06/26.

Levels Of Support And Resistance For IRON Stock

The 24-hour chart illustrates a support level at 76.24, which if violated will result in even more drops to 75.11. On the upside, there is a resistance level at 78.44. A further resistance level may holdings at 79.51.

How much short interest is there in Disc Medicine Inc?

A steep rise in short interest was recorded in Disc Medicine Inc stocks on 2025-12-15, dropping by -0.55 million shares to a total of 2.46 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 3.02 million shares. There was a decline of -22.38%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on February 27, 2025 when TD Cowen began covering the stock and recommended ‘”a Buy”‘ rating.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.